• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

原癌基因Ret是胶质细胞源性神经营养因子(GDNF)受体复合物的一个组成部分,其表达在帕金森病患者的黑质神经元中持续存在。

Expression of the proto-oncogene Ret, a component of the GDNF receptor complex, persists in human substantia nigra neurons in Parkinson's disease.

作者信息

Walker D G, Beach T G, Xu R, Lile J, Beck K D, McGeer E G, McGeer P L

机构信息

Kinsmen Laboratory of Neurological Research and Neurodegenerative Disease Centre, University of British Columbia, Vancouver, BC, Canada.

出版信息

Brain Res. 1998 May 11;792(2):207-17. doi: 10.1016/s0006-8993(98)00131-0.

DOI:10.1016/s0006-8993(98)00131-0
PMID:9593897
Abstract

The proto-oncogene Ret, a membrane-associated receptor protein tyrosine kinase, has recently been shown to be a component of the glial cell line-derived neurotrophic factor (GDNF) receptor complex. GDNF has potent dopaminergic neurotrophic properties and has been suggested as a treatment for Parkinson's disease (PD). In this study, tissue sections of human substantia nigra (SN) from normal and PD cases were examined to determine the pattern of Ret expression in this region, and whether there was continued Ret expression in surviving dopaminergic neurons in PD cases. Using a polyclonal antibody to the amino terminal of Ret, immunoreactivity was localized in the SN to dopaminergic neurons. The antibody predominantly identified punctate deposits within cells. A similar pattern of immunoreactivity was observed in rat and monkey SN neurons. In neurologically normal cases, immunoreactivity was detected in many of the SN neurons. In all the PD cases studied, continued expression of Ret was observed in many of the surviving dopaminergic neurons. In certain cases, it was also detected on cells with the morphology of microglia. Ret expression by microglia was confirmed by immunoblot analysis on the human THP-1 macrophage type cell line. However, these cells did not express the mRNA for GDNFRalpha, the other component of the GDNF receptor complex.

摘要

原癌基因Ret是一种膜相关受体蛋白酪氨酸激酶,最近已被证明是胶质细胞源性神经营养因子(GDNF)受体复合物的一个组成部分。GDNF具有强大的多巴胺能神经营养特性,并已被建议用于治疗帕金森病(PD)。在本研究中,对来自正常和PD病例的人类黑质(SN)组织切片进行检查,以确定该区域Ret的表达模式,以及PD病例中存活的多巴胺能神经元是否持续表达Ret。使用针对Ret氨基末端的多克隆抗体,免疫反应性在SN中定位于多巴胺能神经元。该抗体主要识别细胞内的点状沉积物。在大鼠和猴子的SN神经元中观察到类似的免疫反应模式。在神经功能正常的病例中,在许多SN神经元中检测到免疫反应性。在所有研究的PD病例中,在许多存活的多巴胺能神经元中观察到Ret的持续表达。在某些情况下,在具有小胶质细胞形态的细胞上也检测到了Ret。通过对人THP-1巨噬细胞系进行免疫印迹分析,证实了小胶质细胞表达Ret。然而,这些细胞不表达GDNF受体复合物的另一个组成部分GDNFRα的mRNA。

相似文献

1
Expression of the proto-oncogene Ret, a component of the GDNF receptor complex, persists in human substantia nigra neurons in Parkinson's disease.原癌基因Ret是胶质细胞源性神经营养因子(GDNF)受体复合物的一个组成部分,其表达在帕金森病患者的黑质神经元中持续存在。
Brain Res. 1998 May 11;792(2):207-17. doi: 10.1016/s0006-8993(98)00131-0.
2
Complementary and overlapping expression of glial cell line-derived neurotrophic factor (GDNF), c-ret proto-oncogene, and GDNF receptor-alpha indicates multiple mechanisms of trophic actions in the adult rat CNS.胶质细胞系源性神经营养因子(GDNF)、原癌基因c-ret以及GDNF受体α的互补性和重叠性表达表明成年大鼠中枢神经系统中存在多种营养作用机制。
J Neurosci. 1997 May 15;17(10):3554-67. doi: 10.1523/JNEUROSCI.17-10-03554.1997.
3
Localization of glial cell line-derived neurotrophic factor receptor alpha and c-ret mRNA in rat central nervous system.胶质细胞源性神经营养因子受体α和c-ret mRNA在大鼠中枢神经系统中的定位
J Comp Neurol. 1998 Feb 2;391(1):42-9. doi: 10.1002/(sici)1096-9861(19980202)391:1<42::aid-cne4>3.0.co;2-r.
4
Functional receptor for GDNF encoded by the c-ret proto-oncogene.由原癌基因c-ret编码的GDNF功能性受体。
Nature. 1996 Jun 27;381(6585):785-9. doi: 10.1038/381785a0.
5
ret receptor tyrosine kinase immunoreactivity is altered in glial cell line-derived neurotrophic factor-responsive neurons following lesions of the nigrostriatal and septohippocampal pathways.在黑质纹状体和隔海马通路损伤后,胶质细胞源性神经营养因子反应性神经元中的ret受体酪氨酸激酶免疫反应性发生改变。
Neuroscience. 1997 Sep;80(1):9-16. doi: 10.1016/s0306-4522(97)00122-x.
6
Regulation of c-Ret, GFRalpha1, and GFRalpha2 in the substantia nigra pars compacta in a rat model of Parkinson's disease.帕金森病大鼠模型中黑质致密部c-Ret、GFRalpha1和GFRalpha2的调控
J Neurobiol. 2002 Sep 15;52(4):343-51. doi: 10.1002/neu.10082.
7
GFRalpha-1 mRNA in dopaminergic and nondopaminergic neurons in the substantia nigra and ventral tegmental area.黑质和腹侧被盖区中多巴胺能和非多巴胺能神经元中的GFRalpha-1信使核糖核酸
J Comp Neurol. 2001 Dec 10;441(2):106-17. doi: 10.1002/cne.1400.
8
Intrastriatal grafting of a GDNF-producing cell line protects striatonigral neurons from quinolinic acid excitotoxicity in vivo.移植能产生胶质细胞源性神经营养因子(GDNF)的细胞系至纹状体内,可在体内保护黑质纹状体神经元免受喹啉酸兴奋性毒性损伤。
Eur J Neurosci. 1999 Jan;11(1):241-9. doi: 10.1046/j.1460-9568.1999.00433.x.
9
Evidence for a ligand-specific signaling through GFRalpha-1, but not GFRalpha-2, in the absence of Ret.在缺乏Ret的情况下,存在通过GFRalpha-1而非GFRalpha-2进行配体特异性信号传导的证据。
J Neurosci Res. 2001 Nov 1;66(3):390-5. doi: 10.1002/jnr.1231.
10
Effect of 6-hydroxydopamine on striatal GDNF and nigral GFRalpha1 and RET mRNAs in the adult rat.6-羟基多巴胺对成年大鼠纹状体胶质细胞源性神经营养因子、黑质GFRα1和RET mRNA的影响。
Brain Res Mol Brain Res. 2003 Oct 7;117(2):129-38. doi: 10.1016/s0169-328x(03)00289-4.

引用本文的文献

1
GDNF Therapy: Can We Make It Work?GDNF 疗法:我们能让它发挥作用吗?
J Parkinsons Dis. 2021;11(3):1019-1022. doi: 10.3233/JPD-212706.
2
GDNF, A Neuron-Derived Factor Upregulated in Glial Cells during Disease.胶质细胞源性神经营养因子,一种在疾病期间于胶质细胞中上调的神经元衍生因子。
J Clin Med. 2020 Feb 7;9(2):456. doi: 10.3390/jcm9020456.
3
GDNF-expressing macrophages mitigate loss of dopamine neurons and improve Parkinsonian symptoms in MitoPark mice.表达 GDNF 的巨噬细胞减轻 MitoPark 小鼠多巴胺神经元的丢失并改善帕金森病症状。
Sci Rep. 2018 Apr 3;8(1):5460. doi: 10.1038/s41598-018-23795-4.
4
Glial Cell Line-Derived Neurotrophic Factor Gene Delivery in Parkinson's Disease: A Delicate Balance between Neuroprotection, Trophic Effects, and Unwanted Compensatory Mechanisms.胶质细胞源性神经营养因子基因递送治疗帕金森病:神经保护、营养作用与不良代偿机制之间的微妙平衡
Front Neuroanat. 2017 Apr 10;11:29. doi: 10.3389/fnana.2017.00029. eCollection 2017.
5
Gene therapy approaches in the non-human primate model of Parkinson's disease.帕金森病非人灵长类动物模型中的基因治疗方法。
J Neural Transm (Vienna). 2018 Mar;125(3):575-589. doi: 10.1007/s00702-017-1681-3. Epub 2017 Jan 27.
6
Glial Cell Line-Derived Neurotrophic Factor Family Members Reduce Microglial Activation via Inhibiting p38MAPKs-Mediated Inflammatory Responses.胶质细胞源性神经营养因子家族成员通过抑制p38丝裂原活化蛋白激酶介导的炎症反应来减少小胶质细胞的激活。
J Neurodegener Dis. 2014;2014:369468. doi: 10.1155/2014/369468. Epub 2014 Jun 9.
7
Gene therapy for the treatment of Parkinson's disease: the nature of the biologics expands the future indications.基因治疗帕金森病:生物制剂的性质拓展了未来的适应证。
Pharmaceuticals (Basel). 2012 Jun 4;5(6):553-90. doi: 10.3390/ph5060553.
8
Is GDNF beneficial in Parkinson disease?胶质细胞源性神经营养因子(GDNF)对帕金森病有益吗?
Nat Rev Neurol. 2011 Sep 20;7(11):600-2. doi: 10.1038/nrneurol.2011.149.
9
Development of an in vitro model to evaluate the regenerative capacity of adult brain-derived tyrosine hydroxylase-expressing dopaminergic neurons.建立体外模型评价成年脑源性表达酪氨酸羟化酶的多巴胺能神经元的再生能力。
Neurochem Res. 2011 Jun;36(6):967-77. doi: 10.1007/s11064-011-0435-0. Epub 2011 Mar 6.
10
Differential expression of c-Ret in motor neurons versus non-neuronal cells is linked to the pathogenesis of ALS.c-Ret 在运动神经元与非神经元细胞中的差异表达与 ALS 的发病机制有关。
Lab Invest. 2011 Mar;91(3):342-52. doi: 10.1038/labinvest.2010.203. Epub 2011 Jan 31.